PresseKat - ERBD invests in Russian Pharma Company

ERBD invests in Russian Pharma Company

ID: 592323

(firmenpresse) - Since their establishment in 1991 the ERBD has become the largest financial investor in their region of operations which stretches from central Europe and the Western Balkans to central Asia. With the ability and willingness to bear risk on behalf of their clients, in order to help countries in the region to become open market economies. The ERBD is owned by 63 countries, the European Union and the European Investment Bank.

Now the EBRD is going to buy a minority equity stake of around 15 per cent in Russia’s OSSC. Katren is one of the three largest national pharmaceutical distributers in Russia, Ukraine and Kazakhstan. This investment will give the EBRD the right to nominate two members for election to Katren´s board of directors. It is interesting to admit that prior to this deal, the Bank had already invested over 300 Million Euro in the pharmaceutical industry in nine of the EBRD´s 29 countries of operation.

Chameleon Pharma Consulting comments: Katren has shown a very good performance over the last years and has worked its way up from a small local pharma distributor to a leading national TOP 3 player in Russia. It seems that the company is also one of the few Russian players, who has achieved a top position in Ukraine and Kazakhstan, beside their Russian base business. In this way companies are limiting the potential because of cultural issues between the countries.




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:

Chameleon Pharma Consulting is the healthcare and Pharma consulting expert for the CIS and Eastern European markets. Except for acquisition of targets and due diligence consulting, a part of the major business of Chameleon Pharma Consulting is the search for dynamic and highly-productive Healthcare sale and marketing partners on the CEE & GUS markets.



PresseKontakt / Agentur:

Chameleon Pharma Consulting
Am Tempelhofer Berg 6
10965 Berlin
Germany
Tel: +49 30 648 35 163
Fax: +49 30 648 32 008
service(at)chameleon-pharma.com
www.chameleon-pharma.com

Ansprechpartner: Olga Kiefer
Tel: 030 648 35 164
E-mail: olki(at)chameleon-pharma.com



drucken  als PDF  an Freund senden  Selling of medicine in Internet is not allowed in Ukraine Polfarma increased its stake in Russian pharma company
Bereitgestellt von Benutzer: ChameleonPharma
Datum: 09.03.2012 - 14:02 Uhr
Sprache: Deutsch
News-ID 592323
Anzahl Zeichen: 1432

Kontakt-Informationen:
Ansprechpartner: Olga Kiefer
Stadt:

Berlin


Telefon: 030 648 25 164

Kategorie:

Pharma


Meldungsart: Finanzinformation
Versandart: Veröffentlichung

Diese Pressemitteilung wurde bisher 0 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"ERBD invests in Russian Pharma Company"
steht unter der journalistisch-redaktionellen Verantwortung von

Chameleon Pharma Consulting (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

CHAMELEON PHARMA CONSULTING auf der EXPOPHARM ...

Chameleon Pharama Consulting ist ein junges Unternehmen, das sich aber rasch als zuverlässiger und erfolgreicher Partner für die Markterweiterung im Gesundheitsbereich etabliert hat. 60 erfolgreich abgeschlossene Consulting-Projekte in den letzten ...

Polfarma increased its stake in Russian pharma company ...

The joint-stock company Polfarma Pharmaceutical Factory increased its stake in OJSC Integrated Chemical and Pharmaceutical Enterprise Akrikin from 72.54% to 98.17%. Akrikhin is the fifth largest local producer by revenue 2010 and one of the fastes ...

Alle Meldungen von Chameleon Pharma Consulting